摘要
采用文献考证与实地调查相结合的方法,对常用藏药材"蒂达"的名称、品种分类及其基原进行了考证和整理。结果表明,"蒂达"的名称、品种和基原极为复杂混乱,是导致其缺乏和难以制定药材质量控制标准的关键制约因素。类似状况在民族药中普遍存在,反映出了对民族药进行品种整理的必要性和迫切性。由于古代文献对于药物基原的形态描述往往较为简单,多数情况下仅根据文献考证难以准确确定其基原,在进行民族药品种整理时,还应"尊古不泥古",注重古今药材品种、基原的历史变迁和现实资源、临床使用状况的调查,并积极借鉴现代化学、生物活性评价等的研究成果,既继承民族医药的特色与优势,又推动其现代化发展。
Integrating textual criticism literatures with field survey,the name,classification and botanical originals of breeds of Tibetan medicine 'Dida' were discussed in this paper.The results showed that it s very intricate and confusion in the names,breeds and botanical originals of 'Dida',and those were the key restricting factors resulting in shortfall and difficult formulation in quality standard of 'Dida'.The similar situations are existing universally in ethnodrugs,and reflecting the necessity and urgency t...
出处
《中国中药杂志》
CAS
CSCD
北大核心
2009年第23期3139-3144,共6页
China Journal of Chinese Materia Medica
基金
国家科技支撑计划项目(2006BAI06A11-12)
关键词
蒂达
文献考证
名称与品种整理
藏药
'Dida'
textual criticism
collate name and breed
Tibetan medicine
